Fact CheckerSign in

NCT05792176Completed

Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study

A Randomized Controlled Trial of Ukulele Playing Compared to Music Listening to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study

Source: ClinicalTrials.gov · Last updated 13 Mar 2025

Brief summary (registry, in English)

Over the past 10 years, the rates of multiple sclerosis (MS) have nearly doubled in the United States. This chronic, neuroinflammatory, and neurodegenerative disease is most often diagnosed between the ages of 20-40. Cognitive impairment effects up to 70% of people with MS (PwMS) and has a detrimental impact on mental health, social connections, and employment. Further, up to 50% of PwMS also struggle with depression. Numerous cognitive rehabilitation programs are available to address cognitive impairment, but few interventions have simultaneous effects on cognition and emotional well-being. Music interventions have potential to fill this gap. Brain imaging studies on music and emotion show that music can modulate activity in the brains structures that are known to be crucially involved in emotion. Further, music engages areas of the brain that are involved with paying attention, making predictions, and updating events in our memory. The purpose of this study is to determine the feasibility of an online musical training intervention (MTI) for PwMS and explore the potential effect on cognition, psychosocial, and functional well-being compared to an active control group (music listening (ML)). The specific aims are to: 1) determine the feasibility and acceptability of delivering the MTI virtually over three months to PwMS; 2) evaluate the effect of the MTI on cognitive functioning (processing speed, working memory, cognitive flexibility, response inhibition), psychosocial (anxiety, depression, stress, quality of life, self-efficacy) and functional (insomnia) well-being compared to ML; and 3) (exploratory aim) to utilize non-invasive neuroimaging to determine if pre-intervention brain activity predicts post-intervention cognitive functioning.

Status (registry)
Completed
Study type
Interventional
Enrollment
29 (actual)
First submitted
16 Feb 2023
Start date
27 Mar 2023
Primary completion date
1 Oct 2024
Lead sponsor
University of Texas at Austin
NCT number
NCT05792176

What you commit to

  • Study type: Interventional
  • Participants enrolled: 29
  • From 27 Mar 2023 to the primary completion date, 1 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosed with another neurological condition that causes cognitive impairment

Other

  • MS exacerbation within the last 30 days
  • Unable to travel to The University of Texas at Austin for fNIRS data collection
  • Professional musician (primary source of income)

Who the study is looking for

  • Diagnosed with multiple sclerosis (relapsing remitting, secondary progression, primary progressive)
  • Diagnosed more than 6 months prior to starting study
  • Self-reported cognitive impairment as assessed by having at least 5 problems "sometimes" or more often on the Perceived Deficits Questionnaire
  • Read, write, and understand English
  • Access to computer and zoom

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Texas at Austin
Coordinator of this site? Confirm its status
AustinUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.